Used with standard asthma inhalers, the POCKETFLOW®Spacer is designed to ensure optimal fluid flow through the chamber and is compact and portable, easy to use and clean and cost-effective to produce. Aimed primarily at the paediatric market, it can also be used by adults as an alternative to large volume spacers when out and about, during sport and when traveling…
Pressurised metered dose inhalers (pMDI) are widely used for the long-term management of asthma. However there are a number of problems associated with their use. The amount of drug delivered to the lower airway can be limited by the size of the particles produced, there may be problems with lack of co-ordination between actuation and dose inhalation or adverse effects including oral candidiasis and dysphonia could occur.
Large volume spacer devices, introduced to overcome these problems, can create difficulties themselves as they are large and cumbersome, bulky to carry around and complicated for children to use.
The release goes on to claim that the new device, the main benefit of which seems to be that it’s smaller and cheaper, could save “up to £11.5 million per year”